Lekarna.cz's net debt stood at CZK -50.5 mil and accounted for -47.9% of equity at the end of 2021. The ratio is down 9.85 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of -85.1% in 2007 between 2006 and 2021. The average for the last five years was 22.8%.
Net debt to EBITDA was calculated at -0.767x at the end of the year. ERROR: A non-numeric value encountered That is down from 0.754x seen in 2016. The ratio reached a high of 10.1x in 2009 and a low of -17.7x in 2018.
The company’s cost of funding amounted to 0.916% in 2021, down which is above the 5-year of 1.67%. Funding costs have “eaten” some 0.495% of the operating profit generated in 2019.
You can see all the company’s data at Lekarna.cz profile, or you can download a report on the company in the report section.
Helgi Library 
